Turi S, Németh I, Bodrogi T
Acta Paediatr Hung. 1984;25(4):399-407.
Serum and urinary kallikrein activities were determined from the arginine-esterase activities in various groups of kidney diseases and were compared with urinary beta-glucuronidase excretion, urinary output, urinary protein content and creatinine clearance. Serum arginine-esterase activity was significantly augmented in the active stage of diffuse renal diseases but was not related to the severity of parenchymal damage. The values improved during remission; the enzyme activity in chronic uraemic patient was as low as in the control sera. There was a positive correlation between urinary output and serum arginine-esterase activity, and consequently serum kallikrein might have an enhancing effect on diuresis.
通过测定各类肾脏疾病患者的精氨酸酯酶活性来确定血清和尿液激肽释放酶活性,并将其与尿β-葡萄糖醛酸酶排泄、尿量、尿蛋白含量及肌酐清除率进行比较。弥漫性肾脏疾病活动期血清精氨酸酯酶活性显著升高,但与实质损害的严重程度无关。缓解期该值有所改善;慢性尿毒症患者的酶活性与对照血清一样低。尿量与血清精氨酸酯酶活性之间存在正相关,因此血清激肽释放酶可能对利尿有增强作用。